Compare ERIC & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ERIC | TEVA |
|---|---|---|
| Founded | 1876 | 1901 |
| Country | Sweden | Israel |
| Employees | 88826 | 32842 |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.9B | 39.9B |
| IPO Year | N/A | N/A |
| Metric | ERIC | TEVA |
|---|---|---|
| Price | $12.64 | $34.46 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | $11.00 | ★ $38.63 |
| AVG Volume (30 Days) | ★ 9.8M | 4.7M |
| Earning Date | 04-17-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.82% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.83 | $2.97 |
| P/E Ratio | ★ $12.13 | $28.19 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.16 | $14.99 |
| 52 Week High | $13.77 | $37.35 |
| Indicator | ERIC | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 49.54 | 51.83 |
| Support Level | $9.37 | $33.61 |
| Resistance Level | N/A | $35.37 |
| Average True Range (ATR) | 0.33 | 0.88 |
| MACD | -0.09 | -0.17 |
| Stochastic Oscillator | 12.70 | 63.34 |
Ericsson is a networking equipment and software provider, primarily selling mobile networking equipment and services to wireless service providers. Ericsson operates in three segments: networks, cloud software and services, and enterprise. While large wireless carriers are its largest customers, Ericsson has expanded its offerings for large enterprises. These products and services include private 5G networking, contact centers as a service, and application performance interfaces. Ericsson aims to combine its 5G network expertise with cloud-native, as-a-service platforms offering a more comprehensive hardware and software package. Ericsson also monetizes its research and development investments by licensing patents to handset manufacturers.
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.